Using attentional bias modification as a cognitive vaccine against depression
Using attentional bias modification as a cognitive vaccine against depression
Background
Negative attentional biases are thought to increase the risk of recurrence in depression, suggesting that reduction of such biases may be a plausible strategy in the secondary prevention of the illness. However, no previous study has tested whether reducing negative attentional bias causally affects risk factors for depressive recurrence. The current experimental medicine study reports the effects of a computerized attentional bias modification (ABM) procedure on intermediate measures of the risk of depressive recurrence (residual depressive symptoms and the cortisol awakening response) in patients with recurrent depression.
Methods
Sixty-one patients with at least two previous episodes of depression who were currently in remission were randomized to receive either an active (positive) or placebo computer-based ABM regime. The ABM regime presented either pictures of faces or words. Residual depressive symptoms, measured using the Beck Depression Inventory and the cortisol awakening response were measured immediately before and after completion of the bias modification and then again after 4 weeks' follow-up.
Results
Positive, face-based ABM reduced both measures of recurrence risk (Beck Depression Inventory and cortisol awakening response). This effect occurred during the month following completion of bias modification. Word-based modification did not influence the outcome measures.
Conclusions
Positive face-based ABM was able to reduce intermediate measures of recurrence risk in previously depressed patients. These results suggest that ABM may provide a “cognitive vaccine” against depression and offer a useful strategy in the secondary prevention of the illness.
572-579
Browning, M.
5e31922b-2a63-45e4-82f4-ea64d4efb720
Holmes, E.A.
a6379ab3-b182-45f8-87c9-3e07e90fe469
Charles, M.
ccadf2b9-3e2c-4d9d-9544-6010e57013cf
Cowen, P.J.
3cab01a5-92b0-497f-bc3c-c7770436a912
Harmer, C.J.
352caf0e-94c7-4b97-a224-272edd6401e5
1 October 2012
Browning, M.
5e31922b-2a63-45e4-82f4-ea64d4efb720
Holmes, E.A.
a6379ab3-b182-45f8-87c9-3e07e90fe469
Charles, M.
ccadf2b9-3e2c-4d9d-9544-6010e57013cf
Cowen, P.J.
3cab01a5-92b0-497f-bc3c-c7770436a912
Harmer, C.J.
352caf0e-94c7-4b97-a224-272edd6401e5
Browning, M., Holmes, E.A., Charles, M., Cowen, P.J. and Harmer, C.J.
(2012)
Using attentional bias modification as a cognitive vaccine against depression.
Biological Psychiatry, 72 (7), .
(doi:10.1016/j.biopsych.2012.04.014).
Abstract
Background
Negative attentional biases are thought to increase the risk of recurrence in depression, suggesting that reduction of such biases may be a plausible strategy in the secondary prevention of the illness. However, no previous study has tested whether reducing negative attentional bias causally affects risk factors for depressive recurrence. The current experimental medicine study reports the effects of a computerized attentional bias modification (ABM) procedure on intermediate measures of the risk of depressive recurrence (residual depressive symptoms and the cortisol awakening response) in patients with recurrent depression.
Methods
Sixty-one patients with at least two previous episodes of depression who were currently in remission were randomized to receive either an active (positive) or placebo computer-based ABM regime. The ABM regime presented either pictures of faces or words. Residual depressive symptoms, measured using the Beck Depression Inventory and the cortisol awakening response were measured immediately before and after completion of the bias modification and then again after 4 weeks' follow-up.
Results
Positive, face-based ABM reduced both measures of recurrence risk (Beck Depression Inventory and cortisol awakening response). This effect occurred during the month following completion of bias modification. Word-based modification did not influence the outcome measures.
Conclusions
Positive face-based ABM was able to reduce intermediate measures of recurrence risk in previously depressed patients. These results suggest that ABM may provide a “cognitive vaccine” against depression and offer a useful strategy in the secondary prevention of the illness.
This record has no associated files available for download.
More information
Published date: 1 October 2012
Identifiers
Local EPrints ID: 507977
URI: http://eprints.soton.ac.uk/id/eprint/507977
ISSN: 0006-3223
PURE UUID: 00f012aa-f0e0-4170-b24e-a31deebbb4c0
Catalogue record
Date deposited: 08 Jan 2026 17:55
Last modified: 10 Jan 2026 05:08
Export record
Altmetrics
Contributors
Author:
M. Browning
Author:
E.A. Holmes
Author:
M. Charles
Author:
P.J. Cowen
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics